Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

DrMedHealth vs Eve

DrMedHealth
Graded #198

Higher grade

vs+0.20000000000000284
Eve
Graded #212

Lower grade

The verdict

DrMedHealth takes it — 66.2/100 to 66/100, but only just.

DrMedHealth grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. DrMedHealth is a LegitScript-certified US telehealth platform for GLP-1 medical weight loss. Eve is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEven
54
54
Dose & formulationEve +11
77
88
Clinical oversightDrMedHealth +3
82
79
Labs & monitoringDrMedHealth +1
53
52
FulfillmentDrMedHealth +4
71
67
Contract termsDrMedHealth +14
55
41
DrMedHealth · left barEve · right bar

The numbers

MetricDrMedHealthEve
WeighScore66.2/10066/100
GradeCC
Scorecard rank#198#212
Semaglutide$199/mo (starting dose, compounded)$195/mo (compounded)
Tirzepatide$299/mo (starting dose, compounded)$195/mo (compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesYes
Oral / sublingualInjection onlyYes
DrMedHealth

Graded #198 · C

Strengths

  • LegitScript certified telehealth platform
  • Low compounded pricing: semaglutide from $199/mo, tirzepatide from $299/mo
  • Both compounded and FDA-approved branded options available
  • Fast physician review (advertised ~2 hours) with free shipping
  • Compounded by licensed US pharmacies

Where it loses points

  • Compounded GLP-1s are not FDA-approved for safety, efficacy or quality
  • Cash-pay model; insurance generally not accepted for medication
  • Full list of available states not consolidated in one place
  • Site is JavaScript-rendered, limiting easy review of full terms
Eve

Graded #212 · C

Strengths

  • Genuinely women's-health-focused — fills a real gap among gender-neutral GLP-1 competitors
  • Both compounded and brand-name FDA-approved options (Wegovy/Ozempic/Mounjaro) on one platform — rare
  • LegitScript Certified with a verifiable ID
  • Publishes the FDA compounded-medication disclaimer
  • Oral sublingual semaglutide offered alongside injectable

Where it loses points

  • Full states-served list not disclosed publicly
  • 503A pharmacy partner not named, and 503A vs 503B status not specified
  • Named medical director / clinical leadership not disclosed
  • Corporate legal entity not disclosed
  • Governing law / arbitration venue not stated

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard